Next Article in Journal
Effects of Smallanthus sonchifolius Flour on Metabolic Parameters: A Systematic Review
Next Article in Special Issue
Immunomodulation of Macrophages in Diabetic Wound Individuals by Structurally Diverse Bioactive Phytochemicals
Previous Article in Journal
Unveiling the Multifaceted Capabilities of Endophytic Aspergillus flavus Isolated from Annona squamosa Fruit Peels against Staphylococcus Isolates and HCoV 229E—In Vitro and In Silico Investigations
Previous Article in Special Issue
The Therapeutic Potential of Four Main Compounds of Zanthoxylum nitidum (Roxb.) DC: A Comprehensive Study on Biological Processes, Anti-Inflammatory Effects, and Myocardial Toxicity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Genotoxic and Anti-Genotoxic Potential of Hydrosols from Water–Steam Distillation of Oil-Bearing Roses Rosa centifolia L. and Rosa gallica L. from Bulgaria

1
Institute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences, 2 Gagarin Str., 1113 Sofia, Bulgaria
2
Institute for Roses and Aromatic Plants, Agricultural Academy, 49 Osvobojdenie Blvd., 6100 Kazanlak, Bulgaria
3
Institute of Microbiology, Bulgarian Academy of Sciences, 26 Acad. G. Bonchev Str., 1113 Sofia, Bulgaria
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2024, 17(5), 657; https://doi.org/10.3390/ph17050657
Submission received: 19 April 2024 / Revised: 14 May 2024 / Accepted: 16 May 2024 / Published: 20 May 2024

Abstract

:
Rosa centifolia L. and Rosa gallica L. (Rosaceae) are grown as raw materials for valuable essential oils and hydrosols. There are scarce data about the biological activities and the genoprotective potential of the hydrosols of these roses. The aim of the study was to provide information on their cytotoxic/genotoxic activity and anti-cytotoxic/anti-genotoxic capacity against mutagenic N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). The evaluation was performed using classical tests for chromosomal aberrations and micronuclei in the higher plant Hordeum vulgare and human lymphocyte test systems. The experimental schemes included combined hydrosol and mutagen treatment. Both hydrosols (6, 14, 20%) had no cytotoxic effect on barley and showed low genotoxicity in both test systems as the injuries were enhanced to a lesser extent compared to the controls. Lymphocytes were more susceptible than H. vulgare. Under the conditions of combined treatment, it was found that the two hydrosols possessed good anti-cytotoxic and anti-genotoxic potential against MNNG. Both rose products exerted genoprotective potential to a similar extent, decreasing the frequencies of aberrations in chromosomes and micronuclei to a significant degree in both types of cells when non-toxic concentrations of hydrosols were applied before MNNG. This was performed both with and without any inter-treatment time. The observed cytoprotective/genoprotective potential suggests that these hydrosols are promising for further application in phytotherapy and medicine.

1. Introduction

Cell resistance to DNA-damaging agents is essential for the normal functioning of the cellular genome. There has been growing interest in various plant products and compounds of plant origin that help cells to activate their defence mechanisms. Essential oils [1,2,3,4] and hydrosols and extracts [5,6,7,8] of oleaginous plants have many biological effects due to the wide range of compounds they contain. These compounds contribute to their healing effects, including the protection of the genome against injuries caused by factors of different origin.
The Bulgarian flora is extremely rich in herbs and medicinal plants with significant healing potential. It is believed that Bulgaria is one of the main producers of rose essential oil and other aromatic rose products for use in various spheres of human life. Along with Rosa damascena Mill. and Rosa alba L., Rosa centifolia L. and Rosa gallica L. are valuable raw materials used for the production of rose oil and rose hydrosol [9,10,11,12].
Rose hydrosol, also referred to as hydrolat, floral water, or rose water, is obtained during the steam distillation of essential oils or is produced separately. The product contains only a small amount of essential oil. In R. damascena Mill., hydrosol is between 10 and 50% of the yield of pure essential oil, which is 0.03–0.04% of the plant matter [3], whereas it is even less in R. centifolia L., standing at about 0.01% [13]. The hydrosols include some of the main water-soluble components of essential oils as well as other water-soluble secondary metabolites [14,15,16,17,18,19]. Their chemical composition, on the one hand, depends on the profile of the corresponding essential oil, but on the other, it differs from that because of a lack of hydrocarbons [20].
Aromatic products are known to possess valuable biological properties [19,20]. There are many reports on using rose hydrosols in folk medicine for the treatment of cutaneous and mucosal injuries, digestive problems, ophthalmic problems, chronic insomnia, skin and hormonal problems, and neurological problems [21,22,23,24,25]. These products also demonstrate antimicrobial effects [26], anti-inflammatory activity [27], and antimutagenic effects in different cells [28,29].
Rosa centifolia L. is an old rose species cultivated in Bulgaria, Turkey, Morocco, France, and Italy. It is used for the production of concrete, absolute, and hydrosol. It is known as the province rose, cabbage rose, or hundred-leaved rose. Its essential oil is used in cosmetics, as a fragrance in high perfumery, and as a flavor in confectionery. This rose species has been applied as a therapeutic agent for asthma, high blood pressure, bronchitis, diarrhea, dysmenorrhea, cough, fever, fluid retention, insomnia, arthritis, and urinary infections [30,31,32,33,34]. According to Dobreva et al. [12], the hydrosol from this rose grown in Bulgaria has a higher value of essential oil amounts than species from Iran [12]. R. centifolia L. water extract [35] and methanolic extract [36] demonstrate well-expressed antimicrobial activity. The methanolic extract significantly inhibits HIV-1 primary isolates in PM1 cells [37]. Scarce data exist on the cyto- and genoprotective effect of this rose hydrosol. An investigation showed that aqueous extracts of different cultivars reduced the frequency of mutations induced by the mutagen ethyl methane sulfonate in E. coli [29].
Rosa gallica L. is another plant with industrial and ornamental aromatic uses known since ancient times. It is referred to as the French rose or the Provence rose and is grown not only in Bulgaria but also in other countries of Southern and Eastern Europe, as well as in Armenia, Azerbaijan, and Georgia. The amount of essential oil in the Bulgarian R. gallica hydrosol is close to that of R. centifolia [12]. This species has applications in the fragrance industry, cosmetics, medicine, and the culinary industry. Its pharmacological properties, however, have been much less studied than those of R. damascena Mill. There are some reports of its anti-allergic, antioxidant, skin anti-inflammatory, analgesic, gastroprotective, anti-skin ageing, and antibacterial effects [38,39,40,41,42]. Five types of R. gallica var. aegyptiaca leaf extracts show good antioxidant and antimicrobial potential [43]. A study [44] has demonstrated that rose petal extracts significantly inhibit the growth of lung and colorectal cancer cell lines.
The chemical composition of both rose products is much less well studied than that of R. damascena Mill. [13]. Existing data show that R. centifolia and R. gallica aqueous and ethanolic extracts [42,45] and the subcritical extracts with 1,1,1,2-tetrafluoroethane (freon R134a) contain monoterpenoids, sesquiterpenoids, triterpenoids, phenylethanoids, phenylpropanoids, aliphatic hydrocarbons, fatty acids, esters, and waxes [46]. For example, the R. gallica and R. centifolia hydrosols contain various groups of phytochemicals [12], mostly with antioxidant activity (Figure 1).
In recent years, more and more attention has been paid to the possible toxicological and/or genotoxic effects of plant extracts that are used in folk medicine and have valuable therapeutic properties. Despite the therapeutic potential attributed to R. centifolia and R. gallica hydrosols, there are few studies on their cytotoxicity/genotoxicity and genoprotective potential [47]. These aromatic products contain some valuable chemical compounds with excellent biological effects. This suggests that these rose products would have good cyto- and genoprotective effects. The aim of the present work was to investigate the cytotoxic/genotoxic effect and cytoprotective/genoprotective potential of R. centifolia L. and R. gallica L. hydrosols against a well-known alkylating mutagen, N-methyl-N′-nitro-N-nitrosoguanidine (MNNG), in a series of broadly used genotoxicity tests and appropriate experimental schemes in two different test systems. Using more than one assay and test systems that are widely used in genotoxic screening is known to enhance the reliability of the obtained data. The results obtained would pave the way for further research on the potential of these rose products to protect the genome against damage caused by alkylating genotoxins.

2. Results

2.1. Cytotoxic Activity of R. gallica L. and R. centifolia L. hydrosols

The endpoint for the cytotoxicity of rose hydrosols in both H. vulgare and human lymphocytes was the mitotic index (MI) (Figure 2). The applied hydrosol concentrations (6%, 14%) were not cytotoxic for H. vulgare meristems; the value of MI calculated for the treated samples was not significantly different from that of the untreated control. Only the highest concentration (20%) of both rose products had low cytotoxic activity (p < 0.05). The human lymphocyte cultures were more susceptible to the two hydrosols tested in this study. This was more pronounced for the R. gallica hydrosol, where the mitotic activity (i.e., MI values) showed a concentration-dependent trend (p < 0.001) (Figure 2A,B). The R. centifolia hydrosol had a lower cytotoxic effect than the R. gallica hydrosol, but the difference was non-significant.
The values of MI were lower for both barley and human lymphocytes (p < 0.001, p < 0.01) than for the alkylating mutagen MNNG. Only treatment with the highest R. gallica hydrosol concentration (20%) resulted in MI values close to those of the cells treated with MNNG (50 µg/mL).
The second endpoint for cytotoxicity in lymphocyte cells is the nuclear division index (NDI). It is informative about the proliferative activity of the cells after treatment. In the present study, there were non-significant differences between the values of NDI in both the samples treated with rose hydrosols and the untreated cells. There were also non-significant differences between the tested hydrosols (Figure 2C). The NDIs of the hydrosols were higher than those in the samples with MNNG (p < 0.01).

2.2. Anti-Cytotoxic Activity of R. gallica L. and R. centifolia L. hydrosols

Two schemes for the combined treatment of hydrosols and MNNG were applied to test the defensive potential of the rose hydrosols in both test systems: the first one was conditioning treatment with hydrosol followed by a challenge with MNNG and 4 h inter-treatment time between the treatments, and the second was treatment with hydrosol and MNNG without any inter-treatment time. The hydrosols’ concentrations used for these treatments were non-toxic or slightly toxic (20% for barley and 6% for lymphocytes). These concentrations were pre-selected based on our previous study.
In the combined experimental treatment schemes using R. centifolia hydrosol, the value of MI was significantly higher (p < 0.01, p < 0.001) than that of MNNG alone and was close to that of the hydrosol alone (Figure 2A,B). This was observed both in barley and human lymphocytes, regardless of the experimental design. Similar results were obtained for the MI value in the experiments with conditioning treatment with R. gallica hydrosol (20% for barley and 6% for lymphocytes), in a challenge with MNNG (50 μg/mL) with 4 h inter-treatment time, and for treatments without inter-treatment time (Figure 2A,B). The mitotic activity, evaluated based on the MI value in these samples, was higher (p < 0.01, p < 0.001) than that with MNNG alone, and it reached the value of MI with hydrosol in both test systems. As an endpoint for cytotoxicity, the MI value showed that R. centifolia and R. gallica hydrosols have well-expressed anti-cytotoxic potential.
The anti-cytotoxic effect was also detected using the nuclear division index (NDI) as a cytotoxicity endpoint in human lymphocytes. The values of the NDI after treatment with the same experimental schemes with non-toxic concentrations of (R. centifolia and R. gallica) hydrosols and a damaging concentration of MNNG were also significantly higher (p < 0.01) compared to those of MNNG in both test systems. The NDI values were close to those of the single treatment with the relevant hydrosol concentration. No statistical differences were obtained between the NDI values calculated after the combined treatments for both hydrosols (Figure 2C).

2.3. Genotoxic Activity of R. centifolia L. and R. gallica L. hydrosols

The induction of chromosome aberrations (CA) and micronuclei (MI) were used to obtain information about the genotoxicity/anti-genotoxicity of the tested rose hydrosols.
The values of induced CAs after treatment with R. gallica and R. centifolia hydrosols showed a low but statistically significant genotoxic effect (p < 0.001) compared to the negative controls in both test systems (Figure 3A,B). There were no concentration-dependent effects for either hydrosol in plant and human lymphocyte test systems. The R. gallica hydrosol showed lower genotoxicity/clastogenicity than the R. centifolia hydrosol in H. vulgare. The frequency of induced chromosome aberrations ranged from 2.27% ± 0.33 (for 6%) to 4.4% ± 0.29 (for 20%) for R. centifolia and from 2.47% ± 0.37 (for 6%) to 2.80% ± 0.26 (for 20%) for R. gallica. Both hydrosols had very similar values of clastogenicity in the lymphocyte cells, as there were no significant differences between the frequency of the induced chromosome damage (Figure 3B). They ranged from 4.00% ± 1.7 (for 6%) to 4.30% ± 1.50 (for 20%) for R. centifolia, and from 3.60% ± 1.70 (for 6%) to 4.40% ± 0.90 (for 20%) for R. gallica. The lymphocyte cultures were more sensitive to the R. gallica hydrosol than the barley cells; the value of the induced chromosome injuries was slightly higher (Figure 3B).
The genotoxic activity of both rose hydrosols in the applied concentrations was much lower (p < 0.001) than that of the direct mutagen MNNG in both H. vulgare and human lymphocytes in vitro (Figure 3B).
The spectrum of induced chromosome aberrations by R. centifolia hydrosol in H. vulgare included mainly isochromatid breaks (B″), followed by a small percentage of chromatid breaks (B′) and translocations (T), whereas after treatment with R. gallica hydrosol, only isochromatid breaks (B″) and chromatid breaks (B′) were detected (Figure 4A). In human lymphocytes, the R. centifolia hydrosol predominantly induced isochromatid breaks (B″), followed by chromatid breaks (B′), whereas in some variants treated with R. gallica hydrosol (6%), chromatid breaks (B′) were prevalent, followed by isochromatid breaks (B″) (Figure 4B). MNNG induced a wide spectrum of chromosome aberration in both test systems (Figure 4A,B).
To assess the sensitivity of different parts of plant chromosomes to the tested rose hydrosols, aberration “hot spots” in H. vulgare (reconstructed karyotype MK14/2034) were used. The results showed a concentration dependence (Figure 5). Treatment with 6% R. centifolia hydrosol induced 15.4% “hot spots” in segment 21 of chromosome 43 and 15.4% in segment 44 of chromosome 71. Treatment with 14% rose product induced 14.9% “hot spots” in segment 21 of chromosome 43 and 26.5% in segment 44 of chromosome 71. Treatment with 20% hydrosol induced 10.8% “hot spots” in segment 21 of chromosome 43, 24.3% in segment 44 of chromosome 71, and 13.5% in segment 48 of chromosome 71. Overall, the R. centifolia hydrosol alone affected only 2 or 3 out of the 48 inspected chromosome segments.
The aberration “hot spots” after R. gallica hydrosol treatment were also detected in only two or three chromosome segments (Figure 5). The 6% hydrosol treatment affected segment 44 of chromosome 71 (17.1%) and segment 48 of chromosome 71 (14.3%). Treatment with 14% hydrosol affected segment 21 of chromosome 43 (14.6%), segment 44 of 71 (14.6%), and segment 48 of chromosome 71 (12.2%). Treatment with 20% hydrosol affected segment 21 of chromosome 43 (16.3%), segment 44 of 71 (20.9%), and segment 48 (14.0%) of the same chromosome 71.
MNNG showed significant deviation from the random distribution of isochromatid breaks. Aberrations were observed in “hot spots” in 8 out of all 48 segments of barley (Figure 5).
To obtain more informative results about the genotoxic activity of the tested rose hydrosols, the induction of micronuclei (MN) was also assessed (Figure 6). This endpoint was informative about both chromosome damage and mitotic disturbances. As shown in the figure, the induction of micronuclei was dependent on both the test system and hydrosol. It was interesting to note that MN induction was not dependent on the concentration of the rose hydrosol in H. vulgare and in lymphocytes. Barley meristem cells showed the low induction of MN after treatment with R. centifolia or R. gallica hydrosol (Figure 6A). The frequency of observed injuries caused by R. centifolia was in the range from 0.17% ± 0.18 (for 6%) to 0.17% ± 0.10 (for 20%), and for injuries by R. gallica hydrosol the frequency ranged from 0.20% ± 0.10 (for 6%) to 0.32% ± 0.11 (for 20%).
The frequencies of MN induction by both rose hydrosols were statistically significantly higher (p < 0.001) than in the control sample in lymphocyte cultures (Figure 6B). In the samples treated with R. centifolia hydrosol, the observed MN were in the range from 0.38% ± 0.20 (for the 6% hydrosol) to 0.36% ± 0.05 (for 20% hs). In the cultures treated with R. gallica, the MN frequency ranged from 0.70% ± 0.10 (for 6% hs) to 0.80% ± 0.10 (for 20% hs). The R. gallica hydrosol induced a higher frequency (p < 0.01) of MN than the R. centifolia hydrosol (Figure 6B).
In the MN induction assay, the genotoxic effect of both rose hydrosols (in the tested concentrations) was much lower (p < 0.001) than that of MNNG (Figure 6A,B).

2.4. Anti-Genotoxic Activity of R. centifolia L. and R. gallica L. hydrosols

The anti-genotoxic potential of rose hydrosols was assessed, using the induction of chromosome aberrations as an endpoint.
The frequency of chromosome aberrations was significantly decreased (p < 0.001) after conditioning treatment with R. centifolia hydrosol (20% for H. vulgare and 6% for lymphocytes) followed by damaging treatment with MNNG (50 μg/mL) and 4 h inter-treatment (8.93% ± 0.28 in barley and 6.00% ± 1.40 in lymphocytes) compared with that calculated after MNNG treatment alone (18.30% ± 0.49 in barley and 16.00% ± 1.40 in lymphocytes) (Figure 3A,B). The genotoxic effect of the mutagen was also reduced (p < 0.001) in the experimental scheme of combined treatment without any inter-treatment between the rose hydrosol and the mutagen. The frequency of chromosome aberrations was 10.60% ± 0.32 in barley and 6.00% ± 1.40 in human lymphocytes (Figure 3A,B). The anti-genotoxic effect of R. centifolia was manifested in both test systems, regardless of the experimental schemes. The frequency of chromosome aberrations decreased from 1.7 to 2 times in barley and 2.7 times in lymphocyte cultures.
The anti-genotoxic effect of R. gallica hydrosol was also demonstrated on the basis of the level of induced chromosome aberrations. In both schemes involving combined treatment with hydrosols and MNNG, there was a significant decrease (p < 0.001) in the frequency of the aberrations compared with the MNNG treatment alone (Figure 3A,B). This anti-genotoxic effect was manifested in both test systems. The aberrations after combined treatment with hydrosol (20% for H. vulgare and 6% for lymphocytes), followed by 4 h inter-treatment time and challenge with the mutagen (50 μg/mL), were 7.40% ± 0.22 in barley and 5.20% ± 1.10 in lymphocyte cultures. For comparison, those induced by MNNG were 18.30% ± 0.49 in barley and 16.00% ± 1.40 in lymphocytes. Hence, the genotoxic effect of the direct mutagen was reduced nearly twice in H. vulgare and three times in human lymphocytes. The reduction in the chromosome damage induced by MNNG in the treatment scheme without inter-treatment time was more than two times that in barley cells and in lymphocytes (Figure 3A,B). The frequencies of the aberrations induced in both variants with combined treatment were similar.
It is interesting to note that the values of chromosome aberrations were similar in the treatments with the tested rose hydrosols in both the higher plant and lymphocyte cultures. They probably have similar anti-genotoxic potential.
After both types of combined treatment with the hydrosols (R. centifolia or R. gallica) and the mutagen, the spectrum of the observed aberrations included isochromatid breaks (B″), followed by a small percentage of chromatid breaks (B′), translocations (T), and deletions (D). In the same schemes of combined treatment in human lymphocytes, only isochromatid breaks (B″) and chromatid breaks (B′) were detected (Figure 4A,B).
There was a significant protective effect against MNNG after conditioning treatment with hydrosol in the variants with 4 h inter-treatment time and without inter-treatment time. Eight “aberration hot spots” were induced by MNNG treatment, whereas only 2 or 3 were obtained after treatments following the schemes with combined treatment, which was almost independent of the experimental design (Figure 5). This was observed using the R. centifolia hydrosol and the R. gallica hydrosol. The “hot spot” aberrations after conditioning treatment with the R. centifolia hydrosol (20%), followed by 4 h inter-treatment time prior to challenge with MNNG, and those in the samples without any time between treatments decreased 1.4 times and 1.7 times, respectively, as compared with those in the MNNG samples. In combined variants with R. gallica (20%), 1.9 times and 1.5 times fewer “hot spots” were observed, respectively.
The anti-genotoxic potential of rose hydrosols was also assessed, using micronuclei as an endpoint (Figure 6A,B). The induction of micronuclei decreased (p < 0.001) in both H. vulgare and human lymphocytes after combined treatment with R. centifolia and/or R. gallica hydrosols and MNNG compared with the level seen in the samples treated only with mutagen.
In barley, the MN frequency induced by MNNG alone was 1.78% ± 0.29. It was reduced more than four times (0.4% ± 0.21) in the combined variant after conditioning treatment with R. centifolia hydrosol (20%) and with 4 h inter-treatment time prior to a challenge with MNNG. The micronuclei in the variant with combined treatment without any inter-treatment time decreased to a smaller extent (1.02% ± 0.29). The rose hydrosol also showed well-expressed anti-genotoxic effects (p < 0.001) in the samples with combined treatment with R. gallica hydrosol and MNNG, irrespective of the schemes of treatment. The MN frequencies were similar (0.66% ± 0.07 and 0.76% ± 0.13, respectively) (Figure 6A).
The frequencies of MN were lower in the lymphocyte samples treated with conditioning concentrations of the R. centifolia hydrosol (6%), followed by 4 h inter-treatment time and challenges with the mutagen (0.80% ± 0.23), as well as in those without any inter-treatment time (0.74% ± 0.05). The MN induction was reduced by more than three times compared to that in the variants treated with MNNG only (2.80% ± 0.30) (Figure 6B). A similarly well-expressed defence potential was observed in the combined variants using R. gallica hydrosol, where the frequencies of injury were 0.62% ± 0.02 and 0.56% ± 0.08, with and without inter-treatment time, respectively.

3. Discussion

Research into the biological activity of the hydrosols of various medicinal and ornamental plants has become increasingly important because of their widespread use in traditional and folk medicine. Therefore, it is essential that they are safe, non-toxic, and do not induce alterations in the hereditary material of cells. On the other hand, the study of the protective potential of these hydrosols against various genotoxins is also highly beneficial for healthcare. The use of appropriate assays for analysis in different test systems increases the informative nature of the evaluation.
R. centifolia and R. gallica are rose species that are well known in many countries. In addition to essential oils, hydrosols can also be derived from them. As there were limited data about the chemical composition of their hydrosols, our previous study analyzed the chemical compounds in these products using roses grown in the Kazanlak region [12].
Through chromatographic analysis, 21 chemical compounds were detected in both R. centifolia and R. gallica hydrosols [12]. They belonged to several main groups: monoterpene oxygenated derivatives, phenol derivatives, monoterpene hydrocarbons, and hydrocarbons. The high amount of oxygenated compounds in these rose products is due to their higher solubility in water. Hydrocarbons, on the other hand, are less soluble and therefore are present in small quantities. The main chemical compounds in hydrosols are phenylethyl alcohol (36.61% in R. centifolia and 42.47% in R. gallica), geraniol (17.55% in R. centifolia and 24.42% in R. gallica), citronellol + nerol (16.25% in R. centifolia and 8.80% in R. gallica) and linalool, limonene, eugenol, and geranyl acetate. Their presence ranges from 0.38% to 1.54% in the two rose species. These compounds are present in both rose hydrosols, but their quantity depends on the rose species from which the rose product is derived. This suggests some differences in the biological activity of the rose hydrosols.
Despite the use of R. centifolia and R. gallica hydrosols in different spheres of human life, including cosmetics, folk medicine, and the culinary industry, there is scarce information about their cytotoxic and genotoxic effects. In the present study, as an endpoint for cytotoxicity, the MI assay showed that both hydrosols in concentrations of 6% -20% do not induce any cytotoxic effects in barley meristem cells. The lymphocyte cells were more susceptible to these rose products than barley, as the cytotoxic effect increased in a concentration-dependent trend. The presence of cell walls in plants makes their cells less vulnerable to various injuries than lymphocyte cells in vitro due to their different permeabilities to chemical compounds. The presence of some main chemical compounds in the tested hydrosols may explain their observed cytotoxic effects in lymphocytes. The chemical constituents identified in higher quantities in our previous study [12] included geraniol and nerol. They belong to the group of monoterpene oxygenated derivatives, and manifest cytotoxic activity in a concentration-dependent manner in various cell types [48,49]. Geraniol treatment at concentrations of 10–100 µg/mL causes no high cytotoxicity in human lymphocytes, whereas it does not inhibit cell viability in barley cells [49]. Coêlho et al. [50] reported that nerol demonstrated significant cytotoxic effects in Artemia salina and mouse erythrocytes in concentrations ranging from 31.25 to 500 μg/mL. Other researchers [51] have also found that the presence of higher amounts of monoterpenes or even other unidentified compounds in rosemary and sage hydrosols could be responsible for their toxicity. In the present study, it is interesting to note that cell viability was not affected by hydrosol treatment at the applied concentrations, as assessed by NDI. This was an indicator that most of the lymphocyte cells had entered and completed one or even more division cycles after hydrosol treatment and were not seriously damaged. If lymphocytes have extensive chromosome damage, they either die before cell division or are less likely to enter this phase [52]. A similar good proliferative rate (80% or more) was observed in normal lung Mlg and WI-38 cells treated with various concentrations of R. gallica petal extract [44].
In the present study, the genotoxic effect of the rose hydrosols (6–20%) was assessed using two widely applied tests for the induction of chromosome aberrations and micronuclei. Both hydrosols did not show high genotoxicity, but the frequencies of aberrations and micronuclei were higher compared with the non-treated plant cells and cultured human lymphocytes. The DNA of cultured human lymphocytes was more susceptible to hydrosols than that of H. vulgare cells. Previous studies demonstrated that treatment with R. alba L. and R. damascena Mill. hydrosols (3–20%) also increased the frequency of chromosome injuries and micronuclei to a low extent in the used test systems [53,54]. The observed effect is probably due to the chemical compounds in the hydrosols that can interact with both H. vulgare and human lymphocyte DNA. For example, there are large amounts of monoterpenoids and phenyl derivatives. A previous study reported that the monoterpenoid geraniol and monoterpene aldehyde citral A increased the percentage of migrated DNA in the comet tail of H. vulgare meristem cells [55]. Geraniol increased chromosome aberrations and micronuclei in human lymphocytes as well [49]. Silva et al. [56] reported significant DNA damage and chromosomal mutations after nerol application in a medium, and they found high concentrations in human peripheral blood mononuclear cells and HepG2/C3A-cultured cells. It was proposed that the genotoxic effect of these compounds is due to the presence of an oxygen-related hydroxyl group and carbon double bond that can increase the structure’s electronegativity and interfere with metabolic processes involving the electron transfer that leads to interactions with DNA [57]. The observed genotoxic effect of the tested hydrosols can be due not only to a single chemical compound but also to the synergistic action of the chemical compounds present in rose hydrosols, in turn affecting DNA and the mitotic apparatus. A similar effect was observed for aqueous and hydro-methanol extracts of four different plants in mice bone marrow cells [6].
The lack of a clear difference between the genotoxic effect of R. centifolia and R. gallica hydrosols, assessed both by frequencies of chromosome aberrations and micronuclei in plants and human lymphocyte test systems, is probably due to the presence of the same chemical substances in similar amounts in these rose products [12].
On the other hand, the chemical composition of R. centifolia and R. gallica hydrosols obtained in the previous study included the secondary metabolites geraniol, nerol, limonene, linalool, and citronellol [12]. They have well-expressed pharmacological and antioxidant activities [50,58,59,60,61,62,63,64]. Many studies reported that antioxidant compounds also have antimutagenic, anti-genotoxic and anti-cancerogenic effects [7,65,66]. This fact challenged us to study the anti-cytotoxic and anti-genotoxic potential of rose hydrosols against the direct mutagen MNNG. Investigating the defence potential of hydrosols is important in terms of exploring their activity in preventing mutations induced by various genotoxins.
MNNG is a well-known monofunctional alkylating experimental mutagen. It can induce DNA double-strand breaks, intra-strand, and inter-strand crosslinks in various cells [67,68]. Chromosome aberrations, sister chromatid exchanges, DNA strand breaks, and unscheduled DNA synthesis were reported after treatment with MNNG [69]. MNNG reacts with the O6 atom of guanine and forms an O6alkylG adduct that is highly mutagenic [70,71]. This DNA base can miscode and direct the introduction of the incorrect pyrimidine as its complementary base. If the N-alkylated purines are not removed by base excision repair (BER), they cause chromosome aberrations. In addition to its alkylating activity, MNNG can trigger ROS production, resulting in enhanced DNA damage and PARP-1 activation in mouse embryonic fibroblasts [72].
The results show that both rose hydrosols manifest anti-cytotoxic and anti-genotoxic effects in plant cells and in human lymphocytes against MNNG. The cytotoxic effect of MNNG was alleviated, as assessed by cytotoxicity endpoints (MI and NDI). The values of the endpoints for cytotoxicity were significantly decreased compared with those of MNNG alone. This effect was observed irrespective of the experimental schemes of treatment, and occurred with or without inter-treatment time between the hydrosols and the mutagen.
The tested hydrosols from R. centifolia and R. gallica, respectively, decrease the damaging effect of MNNG and demonstrate well-expressed anti-genotoxic potential. This protective potential was observed in both test systems, regardless of the experimental treatment scheme. Both endpoints for genotoxicity, the frequencies of chromosome aberrations and micronuclei, were reduced when non-toxic concentrations (6% for lymphocytes and 20% for H. vulgare) of hydrosol (R. centifolia or R. gallica) were applied before MNNG, with and without any inter-treatment time. It is interesting to note that the number of DNA damage-sensitive fragments, known as “aberration hot spots”, detected in H. vulgare meristems was reduced compared with that induced by the mutagen alone. In addition, the affected sections are mainly located in regions that are less important for maintaining the functionality of the chromosome.
The results agree with our previous study, where the application of R. damascena hydrosol in non-toxic concentrations (6% in lymphocyte cultures and 20% in barley) also demonstrated cyto- and genoprotective effects against the alkylating mutagen MNNG [54]. Similar DNA-protective potential was also reported for the R. alba essential oil [2].
Both hydrosols showed similar anti-genotoxic potential, as the frequencies of chromosome aberrations and micronuclei were similar. This could be attributed to the presence of the same phytochemicals (secondary metabolites), which are present in comparable amounts in both rose products. Examples include monoterpene oxygenated derivatives, as well as phenol compounds that are present in high quantities in these hydrosols [12]. Geraniol, citronellol, nerol, and linalool are present in high amounts in both hydrosols; hence, they can participate in the protective potential of the tested hydrosols. According to many studies, monoterpenes have a leading role in the antioxidant properties of hydrosols. Geraniol and citronellol can inhibit lipid peroxidation in rat brain homogenates [61]. Nerol can decrease the liver damage induced by carbon-tetrachloride (CCl4) [73]. These compounds with good antioxidant and antiradical scavenging activity [19] can suppress DNA injuries. A previous study found that geraniol manifests well-expressed anti-cytotoxic and anti-genotoxic potential against MNNG in both barley and lymphocyte cells [49]. Hence, in addition to the cyto- and genotoxic activity, geraniol and nerol demonstrate protective potential, which indicates their dual role. Some studies reported that certain phytochemicals can both induce and prevent DNA damage [74]. A study with aqueous and hydro-methanol extracts of other plants reported a dual effect of the extracts [6]. The authors demonstrated the genotoxic and antigenotoxic effects of the extracts against the monofunctional alkylating agent MMS.
The anti-cytotoxic/anti-genotoxic effect of the tested R. centifolia and R. gallica hydrosols is not only due to a single phytochemical, but also to a combination of several compounds that act synergistically in the rose products. According to Briskin et al. [75], the protective action or harmful effects of different natural plant products depend on the combined action of their phytochemicals.
The genoprotective effect of the tested rose hydrosols against MNNG probably includes more than one defence mechanism. It may also include the direct damage reversal repair of O6alkylG DNA adducts by the enzyme O6-methylguanine-DNA methyltransferase (MGMT). Another potential mechanism is ROS scavenging, e.g., blocking the binding sites of the reactive species and/or antioxidant activity of the phytochemicals in the hydrosols. Performing more studies using other test systems and methods would contribute to a better understanding of this defence mechanism.
The evaluation of the anti-cytotoxic/anti-genotoxic potential of the hydrosols can be helpful for utilizing their therapeutic potential and performing further investigations on the pharmacological properties of these plant products.

4. Materials and Methods

4.1. Chemicals

An RPMI 1640 lymphocyte culture medium was purchased from Sigma-Aldrich (Steinheim, Germany); we obtained fetal calf serum from Sigma–Aldrich (Sao Paulo, Brazil); we received phytohemagglutinin (PHA) and cytochalasin-B from Sigma-Aldrich (Jerusalem, Israel); and we obtained KCl and acid aceticum glaciale from Sigma-Aldrich Chemie GmbH, Merck (Steinheim, Germany). Solutions of 0.9% NaCl and gentamycin 40 mg were provided from Sopharmacy (Sofia, Bulgaria), and a Giemsa stain solution was obtained from Sigma-Aldrich (Buchs, Switzerland). The experimental mutagen N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) (CAS-Nr.: 70-25-7) was obtained from Fluka-AG (Buchs, Switzerland).

4.2. Preparation of R. gallica L. and R. centifolia L. hydrosols

Fresh flowers of R. gallica and R. centifolia L. were collected from private plantations in the Kazanlak Valley, Bulgaria, during the flowering period of 2020, early in the morning (6:00–8:00 a.m.), as described by Dobreva et al. (2023) [12]. The authenticity of the plants was confirmed by DSc. Nelly Grozeva from Trakia University, Stara Zagora (BG). The voucher number for R. gallica is SOM 178 485 and for R. centifolia it is SOM 178 486. These plants were deposited in the IBER-BAS herbarium. The hydrosols were derived using established technology in Bulgaria. The parameters for distillation using a semi-industrial processing line were as follows: 8 kg of fresh rose flowers for charge and hydro modules (flowers and water) in a ratio of 1:6, with a duration of 3 h at a distillate temperature of 28–30 °C. The first hydrosol obtained from this process was redistilled at a very low speed until an amount equal to the inserted material was obtained using the same apparatus at the same temperature. The rose products were stored at 4 °C in darkness and then sealed in sterilized bottles for further use [12].

4.3. Test Systems

We used two different types of test systems, widely applied in genotoxic screening, that operate on different hierarchical levels: we used the higher plant Hordeum vulgare and human lymphocytes in vitro to study the cytotoxic/genotoxic activity and anti-cytotoxic/anti-genotoxic effects of the rose hydrosols. Tests for the induction of chromosome aberrations (CA) and micronuclei (MN) were used in both test systems. Specifically, experimental schemes with combined treatment, well established in our previous studies, were applied.

4.3.1. Preparation of Plant Test System and Design of Treatment

A reconstructed karyotype (MK14/2034) of H. vulgare (barley) was used for the current experiments [76]. Presoaked seeds of barley (1 h tap water) were germinated for 17 h in Petri dishes on moist filter paper at 24 °C. After the germination of the barley seeds, part of the root tip meristem of H. vulgare was treated with R. gallica and/or R. centifolia hydrosol for 4 h in concentrations of 6%, 14%, and 20% in order to test the cytotoxic and genotoxic activity of each rose product. To test the defence potential of the hydrosols, the meristems were treated by applying experimental schemes with combined treatments. Some of the barley root tips were subjected to conditioning treatment (60 min) with a non-toxic and low toxic concentration of hydrosol 20% (preselected), followed by 4 h inter-treatment time, and after that we applied a damaging concentration of the direct-acting alkylating mutagen MNNG (50 µg/mL). Another part of the root meristem underwent the same treatment, but without any inter-treatment time (see Figure 7). After each treatment, the barley root tips were rinsed in distilled water. For chromosome aberrations, after the time for recovery (18, 21, 24, 27, and 30 h), the root meristems were treated with 0.025% colchicine in a saturated solution of a-bromonaphthalene (2 h) followed, by fixation in ethanol–glacial acetic acid (3:1). Feulgen staining (Schiff’s reagent, 1 h) was carried out after hydrolyzation in 1N HCl at 60 °C (9 min). After that, the roots were macerated in 4% pectinase, and cut root tips meristems were squashed onto slides. Untreated root tip meristems were used as a negative control. The positive control, MNNG, was dissolved in distilled water to create a stock solution. From this, a working concentration of 50 µg/mL was prepared. For scoring MN, colchicine treatment was omitted, and the root tip meristems were fixed after 30 h recovery time [77].

4.3.2. Preparation of Human Lymphocytes In Vitro and Design of Treatment

The lymphocyte cultures with a cell density of 1 × 106 mol/L were prepared from peripheral venous blood of healthy donors. These subjects were non-smoking/non-drinking, aged between 33 and 40 years (men and women), had no recent history of illness, and had not experienced any contact with medications and mutagens. All procedures in this study were carried out in accordance with the Declaration of Helsinki and after obtaining the necessary ethical approval of the Ethics Commission and Academic Unity of the Institute of Biodiversity and Ecosystem Research (protocol dated 18 February 2022). All donors signed written informed consent forms. Each lymphocyte culture, containing 0.5 mL of lymphocyte suspension, 3.5 mL of RPMI 1640 medium, 12% fetal calf serum, 40 mg/mL gentamycin, and 0.1% phytohemagglutinin (PHA), was cultured at 37 °C.
The method of Evans [78] was applied in experiments for the induction of chromosome aberrations (CA). To test the cytotoxic and genotoxic effects of the rose hydrosols, lymphocyte cells were treated (4 h) with R. centifolia and/or R. gallica hydrosol in concentrations of 6%, 14%, and 20% at 18 h after PHA stimulation (G1). To study the anti-cytotoxic/anti-genotoxic potential of both rose products, part of the lymphocytes was subjected to conditioning treatment (60 min) with a non-toxic (preselected) concentration of hydrosol (6%), followed by 4 h inter-treatment time and a challenge with (50 μg/mL) of MNNG (60 min). Another part of the cells was treated with hydrosol. This was followed immediately by mutagen treatment (50 μg/mL) without any inter-treatment time (see Figure 7). After each treatment, the cells were washed in a fresh medium and kept at 37 °C until harvesting. At the 72nd hour after PHA stimulation, 0.02% colchicine was added to each culture, followed by hypotonization with 0.56% KCl, fixation in methanol–acetic acid (3:1, v/v), and stained in 2% Giemsa solution. Non-treated cells were used as a negative control, and treatment with MNNG (50 μg/mL) served as a positive control.
For the micronuclei induction (MN) assay, in order to stop cytokinesis, cytochalasin-B (6 μg/mL) was added to each culture at the 44th hour after PHA stimulation, which was performed according to the cytokinesis-block micronucleus assay (CBMN) [79]. At the 24th hour after Cyt-B treatment, the cells were centrifuged, hypotonized with 0.56% KCl, and fixed in methanol–acetic acid (3:1). After centrifugation, the cell suspension was dropped onto clean slides and stained in 2% Giemsa.

4.4. Endpoints

4.4.1. For Cytotoxicity

The endpoints for cytotoxicity were mitotic index (MI) and nuclear division index (NDI). They were calculated as follows.
The value of the mitotic index (MI) was calculated for each experimental variant in both test systems using the test for chromosome aberrations. It was calculated by the formula MI = A/1000, where A represents the number of metaphases.
In human lymphocyte cultures, cytotoxicity was assessed with one more endpoint, nuclear division index (NDI), using the test for the induction of micronuclei. It was calculated using the following formula, NDI = (N1 + 2N2 + 3N3 + 4N4)/N, where N1–N4 represents the number of cells with 1–4 nuclei and N is the total number of scored cells.

4.4.2. For Genotoxicity

The endpoints for genotoxicity were both the induction of chromosome aberrations (CA) and micronuclei.
For chromosome aberrations, the percentage of metaphases with aberrations (MwA% ± SD) was calculated. More than 3000 cells were determined to be in both test systems for each experimental variant. Chromatid breaks (B′), isochromatid breaks (B″), chromatid translocations (T), and intercalary deletions (D) were determined.
‘Aberration hot spots’ were calculated in barley chromosomes (reconstructed barley karyotype MK14/2034) to obtain detailed information about DNA segments that are susceptible to the tested rose products and the experimental mutagen, respectively. Since in karyotype MK 14/2034, in contrast to the standard barley karyotype, all chromosome pairs differ from each other, it is possible to display locus-specific aberrations in metaphase chromosomes. In addition to the visible differences between the individual pairs of chromosomes, they were divided into 48 segments of approximately the same size. The protocol of Rieger et al. [80] and Jovtchev et al. [81] was used to calculate the aberration frequency and its accumulation in the so-called ‘hot spots’.
The percentage of micronuclei (MN% ± SD) was determined. For each experimental variant, 6000 cells were analyzed to assess the presence of MN and spindle defects, which later form MN too.

4.5. Statistical Analysis

One-way ANOVA with two-tailed Fisher’s exact test (Microsoft Excel 2010) was used for statistical analysis. Differences were considered statistically significant at the levels of * p < 0.05, ** p < 0.01, and *** p < 0.001. All experiments were repeated three times.

5. Conclusions

R. centifolia L. and R. gallica L. hydrosols have weak genotoxic effects in H. vulgare and human lymphocyte cells, with the latter being more susceptible to their impact. Both rose products, when applied in non-toxic concentrations, can ameliorate the cytotoxic/genotoxic effect of the mutagen MNNG in schemes involving combined treatment with the mutagen, irrespective of the test systems used. The protective anti-genotoxic potential was manifested to a similar extent by both rose products, decreasing the frequencies of chromosome aberrations and micronuclei. The obtained data showed that the combination of the phytochemicals present in the extracts contributed to a decrease in the DNA damage induced by the genotoxin.

Author Contributions

Conceptualization, S.G. and G.J.; Designed the research study and wrote the manuscript, S.G., G.J. and T.G.; Investigation and analysis of data, S.G., G.J. and T.A.; Review and editing, T.G., A.D. and M.M.; Provision and analysis of hydrosol, A.D.; Supervision, M.M.; Project administration, management and funding acquisition, M.M. All authors contributed to editorial changes in the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Bulgarian National Science Fund, project N KP-06-H36/17, granted to Milka Mileva, PhD.

Institutional Review Board Statement

The experiments in the present study were conducted in accordance with the Declaration of Helsinki and is approved by the Commission on Ethics and Academic Unity of Institute of Biodiversity and Ecosystem Research (Number: No 1, Date: 18 February 2022).

Informed Consent Statement

Written informed consent has been obtained from the donors to publish this paper.

Data Availability Statement

The data that support the findings from this study are available from the corresponding author upon reasonable request.

Acknowledgments

The authors are grateful to all donors who participated in the experiments.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Karamalakova, Y.D.; Nikolova, G.D.; Kovacheva, N.; Zheleva, A.M.; Gadjeva, V.G. Study of the radical-scavenging activities and radioprotective properties of Bulgarian essential rose oil from Rosa damascena Mill. Bulg. Chem. Commun. 2019, 51, 101–107. [Google Scholar]
  2. Gateva, S.; Jovtchev, G.; Chanev, C.; Georgieva, A.; Stankov, A.; Dobreva, A.; Mileva, M. Assessment of anti-cytotoxic, anti-genotoxic and antioxidant potential of Bulgarian Rosa alba L. essential oil. Caryologia Int. J. Cytol. Cytosyst. Cytogenet. 2020, 73, 71–88. [Google Scholar]
  3. Garzoli, S.; Alarcón-Zapata, P.; Seitimova, G.; Alarcón-Zapata, B.; Martorell, M.; Sharopov, F.; Fokou, P.V.Y.; Dize, D.; Yamthe, L.R.T.; Les, F.; et al. Natural essential oils as a new therapeutic tool in colorectal cancer. Cancer Cell Int. 2022, 22, 407. [Google Scholar] [CrossRef] [PubMed]
  4. Rasgele, P.C.; Altin, N. Characterization of Essential Oils from Medicinal Plants and Assessment of Their Antimutagenic Effects Using Ames Salmonella/Microsomal Test. C. R. Acad. Bulg. Sci. 2023, 76, 192–202. [Google Scholar] [CrossRef]
  5. Boskabady, M.H.; Shafei, M.N.; Zahra Saberi, A.; Amini, S. Pharmacological Effects of Rosa damascena. Iran. J. Basic Med. Sci. 2011, 14, 295–307. [Google Scholar] [PubMed]
  6. Oyeyemi, I.T.; Yekeen, O.M.; Odusina, P.O.; Ologun, T.M. Genotoxicity and antigenotoxicity study of aqueous and hydro-methanol extracts of Spondias mombin L., Nymphaea lotus L. and Luffa cylindrical L. using animal bioassays. Interdiscip. Toxicol. 2015, 8, 184–192. [Google Scholar] [CrossRef] [PubMed]
  7. Dormousoglou, M.; Efthimiou, I.; Antonopoulou, M.; Fetzer, D.L.; Hamerski, F.; Corazza, M.L.; Papadaki, M.; Santzouk, S.; Dailianis, S.; Vlastos, D. Investigation of the Genotoxic, Antigenotoxic and Antioxidant Profile of Different Extracts from Equisetum arvense L. Antioxidants 2022, 11, 1393. [Google Scholar] [CrossRef]
  8. Bernstein, H.; Crowley-Skillicorn, C.S.C.; Bernstein, C.; Payne, C.M.; Dvorak, K.; Garewal, H. Dietary compounds that enhance DNA repair and their relevance to cancer and aging. In New Research on DNA Repair; Landseer, B.R., Ed.; Nova Publishers: New York, NY, USA, 2007; pp. 99–113. ISBN 978-1-60021-385-4. [Google Scholar]
  9. Rusanov, K.; Kovatcheva, N.; Atanassov, A.; Atanassov, I. Microsatellite analysis of oil bearing roses which do not belong to the species Rosa damascena Mill. Bulg. J. Agr. Sci. 2005, 11, 1–9. [Google Scholar]
  10. Kovatcheva, N.; Zheljazkov, V.D.; Astatkie, T. Productivity, oil content, composition, and bioactivity of oil-bearing rose accessions. HortScience 2011, 46, 710–714. [Google Scholar] [CrossRef]
  11. Mahboubi, M. Rosa damascena as holy ancient herb with novel applications. J. Tradit. Complement. Med. 2016, 6, 10–16. [Google Scholar] [CrossRef]
  12. Dobreva, A.; Nedeva, D.; Mileva, M. Comparative Study of the Yield and Chemical Profile of Rose Oils and Hydrosols Obtained by Industrial Plantations of Oil-Bearing Roses in Bulgaria. Resources 2023, 12, 83. [Google Scholar] [CrossRef]
  13. Labadie, C.; Christian Ginies, C.; Guinebretiere, M.-H.; Catherine, M.G.C.; Renard, C.M.G.C.; Cerutti, C.; Carlin, F. Hydrosols of orange blossom (Citrus aurantium), and rose flower (Rosa damascena and Rosa centifolia) support the growth of a heterogeneous spoilage microbiota. Food Res. Int. 2015, 76, 576–586. [Google Scholar] [CrossRef]
  14. Price, L.; Price, S. Understanding hydrolats: The specific hydrosols for aromatherapy: A guide for health professionals. Churchill Livingstone. In A Guide for Health Professionals; Price, L., Price, S., Eds.; Elsevier: London, UK, 2004; ISBN 9780443073168. [Google Scholar]
  15. Ulusoy, S.; Boşgelmez-Tinaz, G.; Seçilmiş-Canbay, H. Tocopherol, carotene, phenolic contents, and antibacterial properties of rose essential oil, hydrosol and absolute. Curr. Microbiol. 2009, 59, 554–558. [Google Scholar] [CrossRef]
  16. Verma, S.R.; Padalia, C.R.; Chauhan, A. Chemical investigation of the volatile components of shade-dried petals of damask rose (Rosa damascena Mill.). Arch. Biol. Sci. 2011, 63, 1111–1115. [Google Scholar] [CrossRef]
  17. Moein, M.; Zarshenas, M.M.; Delnavaz, S. Chemical composition analysis of rose water samples from Iran. Pharm. Biol. 2014, 52, 1358–1361. [Google Scholar] [CrossRef]
  18. Andola, H.C.; Purohit, V.K.; Chauhan, R.S.; Arunachalam, K. Standardize quality standards for aromatic hydrosols. Med. Plants Int. J. Phytomed. Relat. Ind. 2014, 6, 161–162. [Google Scholar] [CrossRef]
  19. Georgieva, A.; Dobreva, A.; Tzvetanova, E.; Alexandrova, A.; Mileva, M. Comparative Study of Phytochemical Profiles and Antioxidant Properties of Hydrosols from Bulgarian Rosa alba L. and Rosa damascena Mill. J. Essent. Oil-Bear. Plants 2019, 22, 1362–1371. [Google Scholar] [CrossRef]
  20. Aćimović, M.G.; Tesevic, V.V.; Smiljanic, K.T.; Cvetkovic, M.T.; Stankovic, J.M.; Kiprovski, B.M.; Sikora, V.S. Hydrolates—By-products of essential oil distillation: Chemical composition, biological activity, and potential uses. Adv. Technol. 2020, 9, 54–70. [Google Scholar] [CrossRef]
  21. Biswas, N.R.; Gupta, S.K.; Das, G.K.; Kumar, N.; Mongre, P.K.; Haldar, D.; Beri, S. Evaluation of ophthacare eye drops—A herbal formulation in the management of various ophthalmic disorders. Phytother. Res. 2001, 15, 618–620. [Google Scholar] [CrossRef] [PubMed]
  22. Jahangir, U.; Urooj, S.; Shah, A.; Ishaaq, M.; Habib, A. A Comparative Clinical Trial of Rose Petal (Gul Gulaab), Rose Hydrosol Diluted (ArqGulaab), and Rose Hydrosol (RuhGulaab) in Insomnia. Internet J. Neurol. 2008, 11, 1–7. [Google Scholar]
  23. Hosseini, M.; GhasemzadehRahbardar, M.; Sadeghnia, H.R.; Rakhshandeh, H. Effects of different extracts of Rosa damascena on pentylenetetrazol-induced seizures in mice. Zhong Xi Yi Jie He Xue Bao 2011, 9, 1118–1124. [Google Scholar] [CrossRef]
  24. Hamedi, A.; Afifi, M.; Etemadfard, H. Investigating Chemical Composition and Indications of Hydrosol Soft Drinks (Aromatic Waters) Used in Persian Folk Medicine for Women’s. Horm. Reprod. Health Cond. 2017, 22, 824–839. [Google Scholar]
  25. Maruyama, N.; Tansho-Nagakawa, S.; Miyazaki, C.; Shimomura, K.; Ono, Y.; Abe, S. Inhibition of Neutrophil Adhesion and Antimicrobial Activity by Diluted Hydrosol Prepared from Rosa damascena. Biol. Pharm. Bull. 2017, 40, 161–168. [Google Scholar] [CrossRef]
  26. Cendrowski, A.; Krasniewska, K.; Przybyl, J.L.; Zielinska, A.; Kalisz, S. Antibacterial and antioxidant activity of extracts from rose fruits (Rosa rugosa). Molecules 2020, 25, 1365. [Google Scholar] [CrossRef]
  27. Tursun, X.; Zhao, Y.; Alat, Z.; Xin, X.; Tursun, A.; Abdulla, R.; Aisa, H. An Anti-inflammatory effect of Rosa rugosa flower extract in lipopolysaccharide stimulated RAW264.7 macrophages. Biomol. Ther. 2016, 24, 184–190. [Google Scholar] [CrossRef] [PubMed]
  28. Prabhu, N.; Elizabath, G.S.; Joice, P.A.; Soumya, T.S. Effect of Rosa multiflora extract on chemical mutagens using Ames assay. Pharma Chem. 2010, 2, 91–97. [Google Scholar]
  29. Kumar, S.; Gautam, S.; Sharma, A. Identification of antimutagenic properties of anthocyanins and other polyphenols from rose (Rosa centifolia) petals and tea. J. Food Sci. 2013, 78, H948–H954. [Google Scholar] [CrossRef] [PubMed]
  30. Sankaranand, R. Evaluation of antitussive activity of Rosa centifolia. IJPSR 2011, 2, 1473–1475. [Google Scholar]
  31. Jitendra, J.; Vineeta, T.; Ashok, K.; Brijesh, K.; Singh, P. Rosa centifolia. Plant Review. Int. J. Res. Pharm. Chem. 2012, 2, 794–796. [Google Scholar]
  32. Archana, B.; Chandragopal, S.S.; Kumar, S. Evaluation of Anti-Inflammatory and Anti-Arthritic Activity of Rosa centifolia (Linn.) Flowers in Experimental Rats. Int. J. Pharm. Res. Sch. 2013, 2, 1–4. [Google Scholar]
  33. Kumar, R.; Nair, V.; Singh, S.; Gupta, Y.K. In vivo antiarthritic activity of Rosa centifolia L. flower extract. Ayu 2015, 36, 341–345. [Google Scholar] [PubMed]
  34. Valiakos, E.; Marselos, M.; Sakellaridis, N.; Constantinidis, T.; Skaltsa, H. Ethnopharmacological approach to the herbal medicines of the “Antidotes” in Nikolaos Myrepsos Dynameron. J. Ethnopharmacol. 2015, 163, 68–82. [Google Scholar] [CrossRef] [PubMed]
  35. Hassanali, N. An Investigation of Antimicrobial Compounds for Immunomodulating and Anti-Adhesion Properties, Pakistan Research Repository. Ph.D. Thesis, University of Karachi, Karachi, Pakistan, 2003; 121p. [Google Scholar]
  36. Jadhav, N.; Kulkarni, S.; Mane, A.; Kulkarni, R.; Palshetker, A.; Singh, K.; Joshi, S.; Risbud, A.; Kulkarni, S. Antimicrobial activity of plant extracts against sexually transmitted pathogens. Nat. Prod. Res. 2015, 29, 1562–15626. [Google Scholar] [CrossRef] [PubMed]
  37. Palshetkar, A.; Pathare, N.; Jadhav, N.; Pawar, M.; Wadhwani, A.; Kulkarni, S.; Singh, K.K. In vitro anti-HIV activity of some Indian medicinal plant extracts. BMC Complement. Med. Ther. 2020, 20, 69. [Google Scholar] [CrossRef]
  38. Lee, M.H.; Nam, T.G.; Lee, I.; Shin, E.J.; Han, A.R.; Lee, P.; Lee, S.Y.; Lim, T.G. Skin anti-inflammatory activity of rose petal extract (Rosa gallica) through reduction of MAPK signaling pathway. Food Sci. Nutr. 2018, 6, 2560–2567. [Google Scholar] [CrossRef] [PubMed]
  39. Shin, E.J.; Han, A.R.; Lee, M.H.; Song, Y.R.; Lee, K.M.; Nam, T.G.; Lee, P.; Lee, S.Y.; Lim, T.G. Extraction conditions for Rosa gallica petal extracts with anti-skin aging activities. Food Sci. Biotechnol. 2019, 28, 1439–1446. [Google Scholar] [CrossRef] [PubMed]
  40. Song, Y.R.; Lim, W.C.; Han, A.; Lee, M.H.; Shin, E.J.; Lee, K.M.; Nam, T.G.; Lim, T.G. Rose petal extract (Rosa gallica) exerts skin whitening and anti-skin wrinkle effects. J. Med. Food. 2020, 23, 870–878. [Google Scholar] [CrossRef] [PubMed]
  41. Jo, S.; Jung, Y.-S.; Cho, Y.-R.; Seo, J.-W.; Lim, W.-C.; Nam, T.-G.; Lim, T.-G.; Byun, S. Oral Administration of Rosa gallica Prevents UVB Induced Skin Aging through Targeting the cRaf Signaling Axis. Antioxidants 2021, 10, 1663. [Google Scholar] [CrossRef] [PubMed]
  42. Puladze, M.; Mulkijanyan, K.; Gogitidze, N.; Sulakvelidze, M.; Novikova, Z.; Mushkiashvili, N.; Getia, M.; Frédérich, M.; Mouithys-Mickalad, A.; Franck, T.; et al. Phytochemical and pharmacological study of Rosa × gallica L. Georgian cultivar essential oil production waste. GSC Biol. Pharm. Sci. 2022, 19, 213–222. [Google Scholar] [CrossRef]
  43. Abdelbaky, A.S.; Mohamed, A.M.H.A.; Alharthi, S.S. Antioxidant and Antimicrobial Evaluation and Chemical Investigation of Rosa gallica var. aegyptiaca Leaf Extracts. Molecules 2021, 26, 6498. [Google Scholar] [CrossRef]
  44. Lim, W.-C.; Choi, H.-K.; Kim, K.-T.; Lim, T.-G. Rose (Rosa gallica) Petal Extract Suppress Proliferation, Migration, and Invasion of Human Lung Adenocarcinoma A549 Cells through via the EGFR Signaling Pathway. Molecules 2020, 25, 5119. [Google Scholar] [CrossRef] [PubMed]
  45. Malar, S.K.; Saradha, M. Comparative Phytochemical Analysis and Mineral Profile of Rosa damascene and Rosa centifolia. Int. J. Pharm. Bio-Med. Sci. 2022, 2, 565–569. [Google Scholar]
  46. Dobreva, A.; Nedeltcheva-Antonova, D.; Nenov, N.; Getchovska, K.; Antonov, L. Subcritical Extracts from Major Species of Oil-Bearing Roses-A Comparative Chemical Profiling. Molecules 2021, 26, 4991. [Google Scholar] [CrossRef] [PubMed]
  47. European Medicines Agency. Assessment Report on Rosa gallica L., Rosa centifolia L., Rosa damascene Mill., flos. 1 July 2014 EMA/HMPC/137298/2013 Committee on Herbal Medicinal Products (HMPC). Available online: https://www.ema.europa.eu/en/documents/herbal-report/draft-assessment-report-rosa-centifolia-l-rosa-gallica-lrosa-damascena-mill-flos_en.pdf (accessed on 9 February 2024).
  48. Carnesecchi, S.; Langley, K.; Exinger, F.; Gosse, F.; Raul, F. Geraniol, a component of plant essential oils, sensitizes human colonic cancer cells to 5-Fluorouracil treatment. J. Pharmacol. Exp. Ther. 2002, 301, 625–630. [Google Scholar] [CrossRef] [PubMed]
  49. Gateva, S.; Jovtchev, G.; Stankov, A.; Georgieva, A.; Dobreva, A.; Mileva, M. The potential of geraniol to reduce cytotoxic and genotoxic effects of MNNG in plant and human lymphocyte test-systems. S. Afr. J. Bot. 2019, 123, 170–179. [Google Scholar] [CrossRef]
  50. Coêlho, M.L.; Islam, M.T.; Oliveira, G.L.S.; Barros de Alencar, M.V.O.; Santos, J.V.O.; dos Reis, A.C.; Ferreira da Mata, A.M.O.; Jardim Paz, M.F.C.; Docea, A.O.; Calina, D.; et al. Cytotoxic and Antioxidant Properties of Natural Bioactive Monoterpenes Nerol, Estragole, and 3,7-Dimethyl-1-Octanol. Adv. Pharmacol. Pharm. Sci. 2022, 2022, 8002766. [Google Scholar] [CrossRef] [PubMed]
  51. Politi, M.; Ferrante, C.; Menghini, L.; Angelini, P.; Flores, G.A.; Muscatello, B.; Braca, A.; De Leo, M. Hydrosols from Rosmarinus officinalis, Salvia officinalis, and Cupressus sempervirens: Phytochemical Analysis and Bioactivity Evaluation. Plants 2022, 11, 349. [Google Scholar] [CrossRef] [PubMed]
  52. Ionescu, M.E.; Ciocirlan, M.; Becheanu, G.; Nicolaie, T.; Ditescu, C.; Teiusanu, A.G.; Gologan, S.I.; Arbanas, T.; Diculescu, M.M. Nuclear Division Index May Predict Neoplastic Colorectal Lesions. Maedica 2011, 6, 173–178. [Google Scholar] [PubMed] [PubMed Central]
  53. Gerasimova, T.; Jovtchev, G.; Gateva, S.; Topashka-Ancheva, M.; Stankov, A.; Angelova, T.; Dobreva, A.; Mileva, M. Study on Cytotoxic and Genotoxic Potential of Bulgarian Rosa damascena Mill. and Rosa alba L. Hydrosols-In Vivo and In Vitro. Life 2022, 12, 1452. [Google Scholar] [CrossRef]
  54. Gateva, S.; Jovtchev, G.; Angelova, T.; Gerasimova, T.; Dobreva, A.; Mileva, M. Cytogenetic Studies on Genoprotective Effect of Rosa damascena Mill. Hydrosol in Plant and Lymphocyte Test Systems. Life 2023, 13, 1753. [Google Scholar] [CrossRef]
  55. Jovtchev, G.; Stankov, A.; Georgieva, A.; Dobreva, A.; Bakalova, R.; Aoki, I.; Mileva, M. Cytotoxic and genotoxic potential of Bulgarian Rosa alba L. essential oil—In vitro model study. Biotechnol. Biotechnol. Equip. 2018, 32, 513–519. [Google Scholar] [CrossRef]
  56. Silva, B.O.; Orlando, J.B.; Pires, C.L.; Hiruma-Lima, C.A.; Gaivão, I.M.; Perazzo, F.F.; Maistro, E.L. Genotoxicity induced by nerol, an essential oil present in citric plants using human peripheral blood mononuclear cells (PBMC) and HepG2/C3A cells as a model. J. Toxicol. Environ. Health Part A 2021, 84, 518–528. [Google Scholar] [CrossRef] [PubMed]
  57. Cristani, M.; D’Arrigo, M.; Mandalari, G.; Castelli, F.; Sarpietro, M.G.; Micieli, D.; Venuti, V.; Bisignano, G.; Saija, A.; Trombetta, D. Interaction of four monoterpenes contained in essential oils with model membranes: Implications for their antibacterial activity. J. Agric. Food Chem. 2007, 55, 6300–6308. [Google Scholar] [CrossRef] [PubMed]
  58. Roberto, D.; Micucci, P.; Sebastian, T.; Graciela, F.; Anesini, C. Antioxidant activity of limonene on normal murine lymphocytes: Relation to H2O2 modulation and cell proliferation. Basic Clin. Pharmacol. Toxicol. 2010, 106, 38–44. [Google Scholar] [CrossRef] [PubMed]
  59. Aprotosoaie, A.C.; Hăncianu, M.; Costache, I.I.; Miron, A. Linalool: A review on a key odorant molecule with valuable biological properties. Flavour. Fragr. J. 2014, 29, 193–219. [Google Scholar] [CrossRef]
  60. Banu, F.; Dawood, N.; Lakshmi, S.Y.; Gopalakrishnan, S.; Brinda, V. Antioxidant Activity of Geraniol on n-Nitrosodiethylamine-induced Hepatocarcinogenesis in Wistar Albino Rats. Indian J. Oncol. Radiat. Biol. 2014, 2, 4–9. [Google Scholar]
  61. Prasad, S.N.; Muralidhara, M. Analysis of the Antioxidant Activity of Geraniol Employing Various In-Vitro Models: Relevance to Neurodegeneration in Diabetic Neuropathy. Asian J. Pharm. Clin. Res. 2017, 10, 101–105. [Google Scholar] [CrossRef]
  62. Ola, O.S.; Sofolahan, T.A. A monoterpene antioxidant, linalool, mitigates benzene-induced oxidative toxicities on hematology and liver of male rats. Egypt. J. Basic Appl. Sci. 2021, 8, 39–53. [Google Scholar] [CrossRef]
  63. Jayaraj, R.L.; Azimullah, S.; Parekh, K.A.; Ojha, S.K.; Beiram, R. Effect of citronellol on oxidative stress, neuroinflammation and autophagy pathways in an in vivo model of Parkinson’s disease. Heliyon 2022, 8, e11434. [Google Scholar] [CrossRef]
  64. Malik, M.N.H.; Tahir, M.N.; Alsahli, T.G.; Tusher, M.H.; Alzarea, S.I.; Alsuwayt, B.; Jahan, S.; Gomaa, H.A.M.; Shaker, M.E.; Ali, M.; et al. Geraniol Suppresses Oxidative Stress, Inflammation, and Interstitial Collagenase to Protect against Inflammatory Arthritis. ACS Omega 2023, 8, 37128–37139. [Google Scholar] [CrossRef]
  65. Aprotosoaie, A.C.; Mihai, C.T.; Vochita, C.; Rotinberg, P.; Trifan, A.; Luca, S.V.; Petreus, T.; Gille, E.; Miron, A. Antigenotoxic and antioxidant activities of a polyphenolic extract from European Dracocephalum moldavica L. Ind. Crops Prod. 2016, 79, 248–257. [Google Scholar] [CrossRef]
  66. Alzandi, A.A.; Taher, E.A.; Al-Sagheer, N.A.; Al-Khulaidi, A.W.; Azizi, M.; Nagui, D.M. Phytochemical components, antioxidant, and anticancer activity of 18 major medicinal plants in Albaha region, Saudi Arabia. Biocatal. Agric. Biotechnol. 2021, 34, 102020. [Google Scholar] [CrossRef]
  67. Black, K.A.; McFarland, R.D.; Grisham, J.W.; Smith, G.J. Cell cycle perturbation and cell death after exposure of a human lymphoblastoid cell strain to N-methyl N’-nitro-N-nitrosoguanidine. Am. J. Pathol. 1989, 134, 53–61. [Google Scholar] [PubMed]
  68. Quiros, S.; Roos, W.P.; Kaina, B. Processing of O6 -methylguanine into DNA double strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles. Cell Cycle 2010, 9, 168–178. [Google Scholar] [CrossRef] [PubMed]
  69. IARC Monographs, Supplement; 1987; Volume 6, pp. 394–398.
  70. Abbott, P.J.; Saffhill, R. DNA synthesis with methylated poly(dC-dG) templates. Evidence for a competitive nature to miscoding by O6-methylguanine. Biochim. Biophys. Acta (BBA) Nucleic Acids Protein Synth. 1979, 562, 51–61. [Google Scholar] [CrossRef]
  71. Kondo, N.; Takahashi, A.; Ono, K.; Ohnishi, T. DNA Damage Induced by Alkylating Agents, and Repair Pathways. J. Nucleic Acids 2010, 19, 543531. [Google Scholar] [CrossRef] [PubMed]
  72. Chiu, L.-Y.; Ho, F.-M.; Shiah, S.-G.; Chang, Y.; Lin, W.-W. Oxidative stress initiates DNA damages MNNG-induced poly (ADP-ribose) polymerase-1-dependent parthanatos cell death. Biochem. Pharmacol. 2011, 81, 459–470. [Google Scholar] [CrossRef]
  73. Mondal, M.; Bala, J.; Mondal, K.R.; Afrin, S.; Saha, P.; Saha, M.; Jamaddar, S.; Roy, U.K.; Sarkar, C. The protective effects of nerol to prevent the toxicity of carbon tetrachloride to the liver in Sprague-Dawley rats. Heliyon 2023, 9, e23065. [Google Scholar] [CrossRef] [PubMed]
  74. Ferguson, L.R. Role of plant polyphenols in genomic stability. Mutat. Res. 2001, 475, 89–111. [Google Scholar] [CrossRef]
  75. Briskin, D.P. Medicinal plants and phytomedicines linking plant biochemistry and physiology to human health. Plant Physiol. 2000, 124, 507–514. [Google Scholar] [CrossRef]
  76. Künzel, G.; Nicoloff, H. Further results on karyotype reconstruction barley. Biol. Zentralbl. 1979, 98, 587–592. [Google Scholar]
  77. Jovtchev, G.; Stergios, M.; Schubert, I. A comparison of N-methyl-N-nitrosourea-induced chromatid aberrations and micronuclei in barley meristems using FISH techniques. Mutat. Res. Toxicol. Environ. Mutagen. 2002, 517, 47–51. [Google Scholar] [CrossRef]
  78. Evans, H. Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. In Handbook of Mutagenicity Test Procedures; Kilbey, B., Legator, M., Nicols, W., Ramel, C., Eds.; Elsevier Science Publishers: Amsterdam, The Netherlands, 1984; pp. 405–427. [Google Scholar]
  79. Fenech, M. Cytokinesis-block micronucleus cytome assay. Nat. Protoc. 2007, 2, 1084–1104. [Google Scholar] [CrossRef]
  80. Rieger, R.; Michaelis, A.; Schubert, I.; Döbel, P.; Jank, H.W. Non-random intrachromosomal distribution of chromatid aberrations induced by X-rays, alkylating agents and ethanol in Vicia faba. Mutat. Res. 1975, 27, 69–79. [Google Scholar] [CrossRef]
  81. Jovtchev, G.; Gateva, S.P.; Stergios, M.; Kulekova, S. Cytotoxic and genotoxic effects of paraquat in Hordeum vulgare and human lymphocytes in vitro. Environ. Toxicol. 2010, 25, 294–303. [Google Scholar] [CrossRef]
Figure 1. Chemical composition of the R. centifolia L. and R. gallica L. hydrosols identified by GC-FID/MS analysis described previously by [12].
Figure 1. Chemical composition of the R. centifolia L. and R. gallica L. hydrosols identified by GC-FID/MS analysis described previously by [12].
Pharmaceuticals 17 00657 g001
Figure 2. Cytotoxic/anti-cytotoxic activity of R. gallica and R. centifolia hydrosols (hs), observed after treatment with hydrosol alone and after combined treatment applying schemes with hydrosol and MNNG, with 4 h inter-treatment time between treatments and without any inter-treatment time. These were assessed on the basis of the value of MI in H. vulgare (A) and human lymphocyte cultures (B), and on the basis of the value of NDI in human lymphocyte cultures (C). Mitotic activity (MI) was calculated as a percent of the negative control. “a” indicates differences between negative control (untreated variant) and the corresponding treatment variant; “b” indicates differences between positive control (MNNG) and the corresponding treatment variant. The statistical differences were assessed as *** p < 0.001, ** p <0.01, * p < 0.05, dashes (-) p > 0.05 non-significantly.
Figure 2. Cytotoxic/anti-cytotoxic activity of R. gallica and R. centifolia hydrosols (hs), observed after treatment with hydrosol alone and after combined treatment applying schemes with hydrosol and MNNG, with 4 h inter-treatment time between treatments and without any inter-treatment time. These were assessed on the basis of the value of MI in H. vulgare (A) and human lymphocyte cultures (B), and on the basis of the value of NDI in human lymphocyte cultures (C). Mitotic activity (MI) was calculated as a percent of the negative control. “a” indicates differences between negative control (untreated variant) and the corresponding treatment variant; “b” indicates differences between positive control (MNNG) and the corresponding treatment variant. The statistical differences were assessed as *** p < 0.001, ** p <0.01, * p < 0.05, dashes (-) p > 0.05 non-significantly.
Pharmaceuticals 17 00657 g002
Figure 3. Genotoxic/anti-genotoxic activity of R. centifolia and R. gallica hydrosols (hs) assessed by the induction of chromosome aberrations after treatment with hydrosol alone and after combined treatment applying schemes with hydrosol and MNNG with 4 h inter-treatment time between treatments, and without any inter-treatment time in H. vulgare (A) and in human lymphocyte cultures (B). “a” indicates differences between negative control (untreated variant) and the corresponding treatment variant; “b” indicates differences between positive control (MNNG) and the corresponding treatment variant. The statistical differences were assessed as *** p < 0.001, ** p <0.01.
Figure 3. Genotoxic/anti-genotoxic activity of R. centifolia and R. gallica hydrosols (hs) assessed by the induction of chromosome aberrations after treatment with hydrosol alone and after combined treatment applying schemes with hydrosol and MNNG with 4 h inter-treatment time between treatments, and without any inter-treatment time in H. vulgare (A) and in human lymphocyte cultures (B). “a” indicates differences between negative control (untreated variant) and the corresponding treatment variant; “b” indicates differences between positive control (MNNG) and the corresponding treatment variant. The statistical differences were assessed as *** p < 0.001, ** p <0.01.
Pharmaceuticals 17 00657 g003
Figure 4. Distribution of the chromosome aberrations observed after treatment with R. gallica and R. centifolia hydrosols (hs) alone, and with combined treatment using experimental schemes with hydrosols and direct mutagen MNNG, with 4 h inter-treatment time between treatments, and without any inter-treatment time in H. vulgare (A) and in human lymphocyte cultures (B).
Figure 4. Distribution of the chromosome aberrations observed after treatment with R. gallica and R. centifolia hydrosols (hs) alone, and with combined treatment using experimental schemes with hydrosols and direct mutagen MNNG, with 4 h inter-treatment time between treatments, and without any inter-treatment time in H. vulgare (A) and in human lymphocyte cultures (B).
Pharmaceuticals 17 00657 g004
Figure 5. Aberration “hot spots” observed in H. vulgare (reconstructed karyotype MK14/2034) meristem root cells after treatment with R. centifolia and R. gallica hydrosols (hs) alone, and after combined treatment in two experimental schemes with hydrosol and direct mutagen MNNG with 4 h inter-treatment time, and without inter-treatment time.
Figure 5. Aberration “hot spots” observed in H. vulgare (reconstructed karyotype MK14/2034) meristem root cells after treatment with R. centifolia and R. gallica hydrosols (hs) alone, and after combined treatment in two experimental schemes with hydrosol and direct mutagen MNNG with 4 h inter-treatment time, and without inter-treatment time.
Pharmaceuticals 17 00657 g005
Figure 6. Genotoxic/anti-genotoxic activity of R. centifolia and R. gallica hydrosols (hs) assessed by the induction of micronuclei (MN) after treatment with hydrosol alone and after combined treatment schemes with hydrosol and MNNG with 4 h inter-treatment time between treatments, and without any intertreatment time in H. vulgare (A) and in human lymphocyte cultures (B). “a” indicates differences between negative control (untreated variant) and the corresponding treatment variant; “b” indicates differences between positive control (MNNG) and the corresponding treatment variant. The statistical differences were assessed as *** p < 0.001, * p < 0.05, dashes (-) p > 0.05 non-significantly.
Figure 6. Genotoxic/anti-genotoxic activity of R. centifolia and R. gallica hydrosols (hs) assessed by the induction of micronuclei (MN) after treatment with hydrosol alone and after combined treatment schemes with hydrosol and MNNG with 4 h inter-treatment time between treatments, and without any intertreatment time in H. vulgare (A) and in human lymphocyte cultures (B). “a” indicates differences between negative control (untreated variant) and the corresponding treatment variant; “b” indicates differences between positive control (MNNG) and the corresponding treatment variant. The statistical differences were assessed as *** p < 0.001, * p < 0.05, dashes (-) p > 0.05 non-significantly.
Pharmaceuticals 17 00657 g006
Figure 7. Schemes of treatment: (A) single treatment with different concentrations of R. centifolia and/or R. gallica hydrosol, (B) combined treatment with hydrosol and MNNG with 4 h inter-treatment time, and (C) combined treatment without any time between treatments in H. vulgare and human lymphocytes.
Figure 7. Schemes of treatment: (A) single treatment with different concentrations of R. centifolia and/or R. gallica hydrosol, (B) combined treatment with hydrosol and MNNG with 4 h inter-treatment time, and (C) combined treatment without any time between treatments in H. vulgare and human lymphocytes.
Pharmaceuticals 17 00657 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gateva, S.; Jovtchev, G.; Angelova, T.; Gerasimova, T.; Dobreva, A.; Mileva, M. Genotoxic and Anti-Genotoxic Potential of Hydrosols from Water–Steam Distillation of Oil-Bearing Roses Rosa centifolia L. and Rosa gallica L. from Bulgaria. Pharmaceuticals 2024, 17, 657. https://doi.org/10.3390/ph17050657

AMA Style

Gateva S, Jovtchev G, Angelova T, Gerasimova T, Dobreva A, Mileva M. Genotoxic and Anti-Genotoxic Potential of Hydrosols from Water–Steam Distillation of Oil-Bearing Roses Rosa centifolia L. and Rosa gallica L. from Bulgaria. Pharmaceuticals. 2024; 17(5):657. https://doi.org/10.3390/ph17050657

Chicago/Turabian Style

Gateva, Svetla, Gabriele Jovtchev, Tsveta Angelova, Tsvetelina Gerasimova, Ana Dobreva, and Milka Mileva. 2024. "Genotoxic and Anti-Genotoxic Potential of Hydrosols from Water–Steam Distillation of Oil-Bearing Roses Rosa centifolia L. and Rosa gallica L. from Bulgaria" Pharmaceuticals 17, no. 5: 657. https://doi.org/10.3390/ph17050657

APA Style

Gateva, S., Jovtchev, G., Angelova, T., Gerasimova, T., Dobreva, A., & Mileva, M. (2024). Genotoxic and Anti-Genotoxic Potential of Hydrosols from Water–Steam Distillation of Oil-Bearing Roses Rosa centifolia L. and Rosa gallica L. from Bulgaria. Pharmaceuticals, 17(5), 657. https://doi.org/10.3390/ph17050657

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop